palbociclib in metastatic breast cancer. discussion of the paloma-2 results.
Published 2 years ago • 445 plays • Length 6:38Download video MP4
Download video MP3
Similar videos
-
13:22
palbociclib and breast cancer
-
8:25
paloma-1 study of palbociclib in er , her2-, breast cancer
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
0:38
debu tripathy, md on the evidence of palbociclib (ibrance) efficacy in the paloma-2 trial
-
5:43
cdk 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer
-
2:45
paloma-3: phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
0:55
dr. turner discusses the paloma-3 trial
-
1:21
dr. richard finn on what’s next for palbociclib after paloma in breast cancer
-
1:29
dr. finn on the phase iii paloma-2 trial in er breast cancer
-
0:37
debu tripathy, md discusses the paloma-2 trial outcomes in er /her2- advanced breast cancer
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
1:07
dr. kari wisinski on palbociclib for metastatic breast cancer
-
1:45
real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib
-
1:05
dr. turner discusses the paloma-3 trial
-
3:02
paloma-3: palbociclib plus fulvestrant in hormone receptor-positive advanced breast cancer
-
6:56
analyses from paloma-3 study, including os data for hr breast cancer
-
5:06
results from the paloma-3 trial for advanced breast cancer